P2-159: Phase III randomized study of oral vinorelbine (oV) and gemcitabine (G) (oVG) versus docetaxel (D) and gemcitabine (DG) as first-line treatment of patients with advanced non-small cell lung cancer (NSCLC): A preliminary report
Agelaki, S, Androulakis, N, Agelidou, A, Agelidou, M, Kotsakis, A, Polyzos, A, Kentepozidis, N, Ziras, N, Mavroudis, D, Georgoulias, VVolume:
2
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/01.JTO.0000283817.86250.51
Date:
August, 2007
File:
PDF, 169 KB
english, 2007